Schedule 13D ownership disclosure

EUPRAXIA PHARMACEUTICALS INC

Common Shares, no par value · CUSIP: 29842P105

Event date: 2026-03-13

Filing-level shares
5,843,215
Percent of class
9.0%
  • Joseph S. FreedmanReported CIK 0002043590

    Shares: 5,843,215 · Class: 9.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-108982
Form type
SCHEDULE 13D/A
Filer
EUPRAXIA PHARMACEUTICALS INC.
CIK
CIK 1581178
Filed
Mar 16, 2026
Reporting period
Mar 13, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub